NO20033967L - Fremgangsmåte for fremstilling av mikropartikler som inneholder metoprolol - Google Patents

Fremgangsmåte for fremstilling av mikropartikler som inneholder metoprolol

Info

Publication number
NO20033967L
NO20033967L NO20033967A NO20033967A NO20033967L NO 20033967 L NO20033967 L NO 20033967L NO 20033967 A NO20033967 A NO 20033967A NO 20033967 A NO20033967 A NO 20033967A NO 20033967 L NO20033967 L NO 20033967L
Authority
NO
Norway
Prior art keywords
preparation
microparticles containing
metoprolol
containing metoprolol
microparticles
Prior art date
Application number
NO20033967A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033967D0 (no
Inventor
Alf Djurle
Mikael Hansson
Malin Soederbom
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20033967D0 publication Critical patent/NO20033967D0/no
Publication of NO20033967L publication Critical patent/NO20033967L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NO20033967A 2001-03-09 2003-09-08 Fremgangsmåte for fremstilling av mikropartikler som inneholder metoprolol NO20033967L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100824A SE0100824D0 (sv) 2001-03-09 2001-03-09 Method III to obtain microparticles
PCT/SE2002/000401 WO2002072074A1 (fr) 2001-03-09 2002-03-06 Procede de preparation de microparticules contenant du metoprolol

Publications (2)

Publication Number Publication Date
NO20033967D0 NO20033967D0 (no) 2003-09-08
NO20033967L true NO20033967L (no) 2003-10-28

Family

ID=20283295

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033967A NO20033967L (no) 2001-03-09 2003-09-08 Fremgangsmåte for fremstilling av mikropartikler som inneholder metoprolol

Country Status (25)

Country Link
US (1) US20040116392A1 (fr)
EP (1) EP1370245B1 (fr)
JP (1) JP2004522798A (fr)
KR (1) KR20030081507A (fr)
CN (1) CN1236761C (fr)
AT (1) ATE295153T1 (fr)
AU (1) AU2002235102B2 (fr)
BR (1) BR0207919A (fr)
CA (1) CA2440167A1 (fr)
DE (1) DE60204125T2 (fr)
ES (1) ES2240691T3 (fr)
HK (1) HK1059737A1 (fr)
HU (1) HUP0303450A2 (fr)
IL (1) IL157777A0 (fr)
IS (1) IS6937A (fr)
MX (1) MXPA03008088A (fr)
NO (1) NO20033967L (fr)
NZ (1) NZ528168A (fr)
PL (1) PL363972A1 (fr)
PT (1) PT1370245E (fr)
RU (1) RU2292878C2 (fr)
SE (1) SE0100824D0 (fr)
UA (1) UA75909C2 (fr)
WO (1) WO2002072074A1 (fr)
ZA (1) ZA200306880B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles
US8006685B2 (en) * 2002-07-05 2011-08-30 Turbochef Technologies, Inc. Re-circulating oven with gas clean-up
SI1915137T1 (sl) 2005-08-10 2013-12-31 Add Advanced Drug Delivery Technologies, Ltd. Pripravek z nadzorovanim sproščanjem za peroralno dajanje
US20070053983A1 (en) * 2005-09-06 2007-03-08 Girish Jain Extended release compositions of metoprolol succinate
BRPI0714586A2 (pt) * 2006-07-28 2013-05-07 Farmaprojects S A formulaÇço farmacÊutica de liberaÇço prolongada de metropolol e processo para a sua preparaÇço
ES2753148T3 (es) * 2007-02-23 2020-04-07 Glatt Air Techniques Inc Método para determinar el peso del recubrimiento que va a ser aplicado para formar una forma de dosificación de liberación controlada
CN101269056B (zh) * 2007-03-19 2010-05-19 天津药物研究院 一种美托洛尔盐类口服脉冲微丸制剂
AU2008311289A1 (en) * 2007-10-10 2009-04-16 Avantor Performance Materials, Inc. Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
CN102641257A (zh) * 2012-03-31 2012-08-22 内蒙古医学院 阿替洛尔缓释微囊及其制备方法
RU2585023C1 (ru) * 2014-12-18 2016-05-27 Общество с ограниченной ответственностью "Нанолек" Способ гранулирования
CN104739805B (zh) * 2015-04-09 2017-12-19 邸蓉 制备琥珀酸美托洛尔缓释微丸的复相乳液法
WO2019183470A2 (fr) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. Nouvelle méthode pour ralentir le rythme ventriculaire
CN115252913A (zh) * 2022-08-02 2022-11-01 赛诺神畅医疗科技有限公司 一种血管给药涂层及其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US653014A (en) * 1899-10-06 1900-07-03 Ashley & Bailey Company Process of silkifying cotton.
SE354851B (fr) * 1970-02-18 1973-03-26 Haessle Ab
DE3565475D1 (en) * 1984-04-07 1988-11-17 Bayer Ag Process and apparatus for the production of granules
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
DE3909455A1 (de) * 1989-03-22 1990-09-27 Hoechst Ag Verfahren zur herstellung von wasserdispergierbaren granulaten
FR2725623A1 (fr) * 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
DE69617245T2 (de) * 1995-08-17 2002-07-25 Csir Pretoria Produkte mit gesteuerter freisetzung
DE19613395A1 (de) * 1996-04-03 1997-10-09 Basf Ag Granulate hygroskopischer, wasserlöslicher Produkte
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19733094A1 (de) * 1997-07-31 1999-02-04 Merck Patent Gmbh Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität
WO1999018935A1 (fr) * 1997-10-15 1999-04-22 Merck Patent Gmbh Preparation d'un auxiliaire d'agglomeration directement compressible
EP0987020A1 (fr) * 1998-09-04 2000-03-22 Pharma Pass LLC Composition contenant du metoprolol et procédé de préparation
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
ES2372746T3 (es) * 2000-09-20 2012-01-26 Jagotec Ag Micropartículas de fibrato estabilizadas.
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles

Also Published As

Publication number Publication date
DE60204125T2 (de) 2006-01-19
UA75909C2 (en) 2006-06-15
ZA200306880B (en) 2004-12-03
BR0207919A (pt) 2004-04-27
HUP0303450A2 (hu) 2004-01-28
IL157777A0 (en) 2004-03-28
NO20033967D0 (no) 2003-09-08
CA2440167A1 (fr) 2002-09-19
RU2003127739A (ru) 2005-03-10
CN1507345A (zh) 2004-06-23
ATE295153T1 (de) 2005-05-15
PL363972A1 (en) 2004-11-29
AU2002235102B2 (en) 2006-08-31
DE60204125D1 (de) 2005-06-16
SE0100824D0 (sv) 2001-03-09
NZ528168A (en) 2005-01-28
US20040116392A1 (en) 2004-06-17
CN1236761C (zh) 2006-01-18
EP1370245A1 (fr) 2003-12-17
JP2004522798A (ja) 2004-07-29
EP1370245B1 (fr) 2005-05-11
KR20030081507A (ko) 2003-10-17
IS6937A (is) 2003-09-03
WO2002072074A1 (fr) 2002-09-19
RU2292878C2 (ru) 2007-02-10
ES2240691T3 (es) 2005-10-16
HK1059737A1 (en) 2004-07-16
MXPA03008088A (es) 2003-12-12
PT1370245E (pt) 2005-08-31

Similar Documents

Publication Publication Date Title
NO20033967L (no) Fremgangsmåte for fremstilling av mikropartikler som inneholder metoprolol
EP1399414A4 (fr) Composes de tetracycline substitues destines au traitement de la malaria
IL219397A0 (en) Compounds for the treatment of metabolic disorders, methods of preparing same, and pharmaceutical compositions containing same
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
MX9805253A (es) Antagonistas del receptor de vitronectina.
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
IL150225A0 (en) Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof
BG105556A (en) New esters derived from substituted phenyl-cyclohexyl compounds
HK1076812A1 (en) Cyanoguanidine prodrugs
DE69229339D1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
AU6566700A (en) Cushioning wax beads for making solid shaped articles
NO20033966L (no) Fremgangsmåte for oppnåelse av mikropartikler inneholdende H+, K+-ATP-ase-inhibitorer
IL157540A (en) Pharmaceutical compositions comprising n-(aryl)-2-arylethenesulfonamides, some such novel compounds and process for their preparation
DE69831409D1 (de) Chalcon-derivate mit antiproliferativer aktivität
PL366381A1 (en) Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives
EP1509220A4 (fr) Composition pharmaceutique destine au traitement de la seborrhee contenant 4-hydroxy-5-methoxy-4- 2-methyl-3-(3-methyl-2-butenyl)-2-oxiranyl -1-oxaspiro 2,5 octane-6-one
IL163608A0 (en) Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
MXPA04010915A (es) Base y procedimiento de conocimiento de recursos humanos dinamicos.
CZ20022240A3 (cs) Mannichovy báze substituovaného 1-a 2-naftolu
PT1126853E (pt) Distribuicao controlada de anti-depressivos
IL134039A0 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
AU2002311623A1 (en) Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
IL144063A0 (en) Process for the preparation of 1,1-cyclohexanediacetic acid
HUP0402417A3 (en) N,n'-disubstituted piperazine compounds process for producing them, pharmaceutical compositions containing them and use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application